Long-acting follicle stimulating hormone analogues and uses...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

Reexamination Certificate

active

07807620

ABSTRACT:
This invention provides FSH analogues having increased serum half-life relative to FSH. This invention also provides related compositions and methods for increasing fertility, egg production and spermatogenesis in a subject.

REFERENCES:
patent: 4179337 (1979-12-01), Davis et al.
patent: 5177193 (1993-01-01), Boime et al.
patent: 5270181 (1993-12-01), McCoy et al.
patent: 5272070 (1993-12-01), Lehrman et al.
patent: 5359033 (1994-10-01), Cate et al.
patent: 5585345 (1996-12-01), Boime
patent: 5661126 (1997-08-01), Donahoe et al.
patent: 5712122 (1998-01-01), Boime et al.
patent: 5728381 (1998-03-01), Wilson et al.
patent: 5759818 (1998-06-01), Boime
patent: 5925549 (1999-07-01), Hsueh et al.
patent: 5958737 (1999-09-01), Boime et al.
patent: 5985611 (1999-11-01), Boime
patent: 6040157 (2000-03-01), Hu et al.
patent: 6103501 (2000-08-01), Boime et al.
patent: 6225449 (2001-05-01), Boime
patent: 6238890 (2001-05-01), Boime et al.
patent: 6242580 (2001-06-01), Boime et al.
patent: 6245896 (2001-06-01), Lee et al.
patent: 6265393 (2001-07-01), Heinrichs
patent: 6274365 (2001-08-01), van de Ven et al.
patent: 6306654 (2001-10-01), Boime et al.
patent: 6635256 (2003-10-01), Boime et al.
patent: 6737515 (2004-05-01), Boime et al.
patent: 6987172 (2006-01-01), Boime et al.
patent: 7081446 (2006-07-01), Lustbader
patent: 7173113 (2007-02-01), Lustbader et al.
patent: 7202215 (2007-04-01), Lustbader
patent: 7442684 (2008-10-01), Lustbader et al.
patent: 2002/0127652 (2002-09-01), Schambye et al.
patent: 2002/0128190 (2002-09-01), Lobel et al.
patent: 2003/0012792 (2003-01-01), Holaday et al.
patent: 2003/0211580 (2003-11-01), Lustbader
patent: 2003/0219875 (2003-11-01), Rosen et al.
patent: 2004/0258685 (2004-12-01), Brunetta et al.
patent: 2005/0166274 (2005-07-01), French et al.
patent: 2007/0128203 (2007-06-01), Giles-Komar et al.
patent: 2008/0008650 (2008-01-01), Fukuda et al.
patent: 2008/0039372 (2008-02-01), Lustbader
patent: 2009/0093411 (2009-04-01), Lustbader et al.
patent: 0322226 (1989-06-01), None
patent: 0957167 (1999-11-01), None
patent: WO-02/072793 (2002-09-01), None
patent: WO-03/064619 (2003-08-01), None
patent: WO 03/064677 (2003-08-01), None
patent: WO-2009/052119 (2009-04-01), None
patent: WO-2010/017290 (2010-02-01), None
Bouloux, P. M., D. J. Handelsman, F. Jockenhovel, E. Nieschlag, J. Rabinovici, W. L. Frasa, J. J. de Bie, G. Voortman, and J. Itskovitz-Eldor (2001) First human exposures to FSH-CTP in hypogonadotrophic hypogonadal males.Hum Reprod, 16, 1592-1597.
Calvo, F. O., H. T. Keutmann, E. R. Bergert, and R. J. Ryan (1986) Deglycosylated human follitropin: characterization and effects on adenosine cyclic 3′,5′-phosphate production in porcine granulosa cells.Biochemistry25, 3938-3943.
Chui, D. K., N. D. Pugh, S. M. Walker, L. Gregory, and R. W. Shaw (1997) Follicular vascularity—the predictive value of transvaginal power Doppler ultrasonography in an in vitro fertilization programme: a preliminary study.Hum. Reprod. 12, 191-196.
Dissen, G. A., H. E. Lara, W. H. Fahrenbach, M. E. Costa, and S. R. Ojeda (1994) Immature rat ovaries become revascularized rapidly after autotransplantation and show a gonadotropin-dependent increase in angiogenic factor gene expression.Endocrinology134, 1146-1154.
Fares, F. A., N. Suganuma, K. Nishimori, P. S. Lapolt, A. J. Hsueh, and I. Boime (1992) Design of a long-acting follitropin agonist by fusing the C-terminal sequence of the chorionic gonadotropin beta subunit to the follitropin beta subunit.Proc. Natl. Acad. Sci. U.S.A. 89, 4304-4308.
Feng, W., M. M. Matzuk, K. Mountjoy, E. Bedows, R. W. Ruddon, and I. Boime (1995) The asparagine-linked oligosaccharides of the human chorionic gonadotropin beta subunit facilitate correct disulfide bond pairing.J. Biol. Chem. 270, 11851-11859.
Ferrara, N., H. Chen, T. Davis-Smyth, H. P. Gerber, T. N. Nguyen, D. Peers, V. Chisholm, K. J. Hillan, and R. H. Schwall (1998) Vascular endothelial growth factor is essential for corpus luteum angiogenesis.Nat. Med. 4, 336340.
Ferrara, N., K. Houck, L. Jakeman, and D. W. Leung (1992) Molecular and biological properties of the vascular endothelial growth factor family of proteins.Endocr. Rev. 13, 18-32.
Krichevsky, A., S. Birken, J. F. O'Connor, K. Bikel, J. Schlatterer, and R. E. Canfield (1994) The development of a panel of monoclonal antibodies to human luteinizing hormone and its application to immunological mapping and two-site assays.Endocrine 2. 511-520.
LeContonnec, J. Y., H. C. Porchet, V. Beltrami, A. Khan, S. Toon, and M. Rowland (1994) Clinical pharmacology of recombinant human follicle-stimulating hormone. II. Single doses and steady-state pharmacokinetics.Fertil. Steril. 61, 679-86.
Lindau-Shapard, B. A., H. A. Brumberg, A. J. Peterson, and J. A. Dias (2001) Reversible immunoneutralization of human follitropin receptor.J. Reprod. Immun. 49, 1-19.
Matzuk, M. M., A. J. Hsueh, P. Lapolt, A. Tsafriri, J. L. Keene, and I. Boime (1990) The biological role of the carboxyl-terminal extension of human chorionic gonadotropin beta-subunit.Endocrinology126, 376-383.
Nargund, G., T. Bourne, P. Doyle, J. Parsons, W. Cheng, S. Campbell, and W. Collins (1996) Associations between ultrasound indices of follicular blood flow, oocyte recovery and preimplantation embryo quality.Hum. Reprod. 11, 109-113.
Pedersen, T. and H. Peters (1968) Proposal for a classification of oocytes and follicles in the mouse ovary.J. Reprod. Fertil. 17, 555-557.
Pierce, J. G. and T. F. Parsons (1981) Glycoprotein hormones: structure and function.Annu. Rev. Biochem. 50, 465-495.
Porchet, H. C., J. Y. LeContonnec, B. Neuteboom, S. Canali, and G. Zanolo (1995) Pharmacokinetics of recombinant human luteinizing hormone.J. Clin. Endocrinol. Metab. 80, 667-73.
Saal, W., H. J. Glowania, and J. Happ (1991) Pharmacodynamics and pharmacokinetics after subcutaneous and intramuscular injection of human chorionic gonadotropin.Fertil. Steril. 56, 225-8.
Sairam, M. R. and P. Manjunath (1982) Studies on pituitary follitropin. XL Induction of hormonal antagonistic activity by chemical deglycosylation.Mol. Cell Endocrinol. 28, 139-150.
Sugahara, T., M. R. Pixley, F. Fares, and I. Boime (1996) Characterization of the O-glycosylation sites in the chorionic gonadotropin beta subunit in vivo using site-directed mutagenesis and gene transfer.J. Biol. Chem. 271, 20797-20804.
Suganuma, N., M. M. Matzuk, and I. Boime (1989) Elimination of disulfide bonds affects assembly and secretion of the human chorionic gonadotropin beta subunit.J. Biol. Chem. 264, 19302-19307.
Van Blerkom, J., M. Antczak, and R. Schrader (1997) The developmental potential of the human oocyte is related to the dissolved oxygen content of follicular fluid: association with vascular endothelial growth factor levels and perifollicular blood flow characteristics.Hum. Reprod. 12, 1047-1055.
Yen, S. S., O. Llerena, B. Little, and O. H. Pearson (1968) Disappearance rates of endogenous luteinizing hormone and chorionic gonadotropin in man.J. Clin. Endocrinol. Metab. 28, 1763-1767.
International Search Report issued Dec. 1, 2003 in connection with PCT International Application No. PCT/US03/02982 (Exhibit B).
Ben-Menahem et al. (2001) The Position of the Alpha and Beta Subunits in a Single Chain Variant of Human Chorionic Gonadotropin Affects the Heterodimeric Interaction of the Subunits and Receptor-Binding Epitope.J. Biol. Chem. 276:29871-879 (Exhibit C).
International Search Report issued Jan. 8, 2007 in connection with related PCT International Application No. PCT/US03/02957(Exhibit D).
Baird, D. (2001) Is there a place for different isoforms of FSH in clinical medicine? IV. The clinician's point of view,Human Reproduction, vol. 16, No. 6, p. 1316-1318 (Exhibit E).
Ulloa-Aguirre, et al. (2001) Endocrine Regulation of Gonadotropin Glycosylation,Archives of Medical Research, vol. 32, p. 520-532 (Exhibit F).
U.S. Appl. No. 10/062,910, filed Jan. 31, 2002, Joyce Lustbader et al.
Advisory Action issued Oct. 6, 2005 in connection with U.S. Appl. No. 10/112,321, filed Mar. 27, 2002.
Amendment submitted Dec. 20, 2006 in conne

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Long-acting follicle stimulating hormone analogues and uses... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Long-acting follicle stimulating hormone analogues and uses..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Long-acting follicle stimulating hormone analogues and uses... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4212503

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.